SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Oakworth Capital Inc.

Oakworth Capital Inc. cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.5% in the fourth quarter, Holdings Channel reports. The fund owned 5,692 shares of the exchange traded fund’s stock after selling 271 shares during the period. Oakworth Capital Inc.’s holdings in SPDR S&P Biotech ETF were worth $513,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Healthcare of Ontario Pension Plan Trust Fund grew its position in SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $141,284,000. Assetmark Inc. grew its holdings in SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after acquiring an additional 588,489 shares during the period. Sivik Global Healthcare LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $29,640,000. Finally, Mirae Asset Securities USA Inc. grew its holdings in SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after buying an additional 300,000 shares during the last quarter.

SPDR S&P Biotech ETF Stock Up 2.3 %

XBI stock opened at $94.70 on Thursday. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The stock has a market capitalization of $7.22 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock’s fifty day simple moving average is $92.88 and its 200-day simple moving average is $96.57.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.